Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
334.4 GBX | +0.87% | +2.64% | +3.96% |
04-25 | Moody’s Affirms Haleon’s Ratings on Strong Operating Performance | MT |
04-24 | Haleon: a new CFO at the end of October | CF |
Business Summary
- oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.;
- Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.;
- medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.;
- respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.;
- vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Number of employees: 25,408
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oral Health
27.7
%
| 2,957 | 27.2 % | 3,136 | 27.7 % | +6.05% |
Pain Relief
23.5
%
| 2,551 | 23.5 % | 2,652 | 23.5 % | +3.96% |
Digestive Health and Other
18.9
%
| 2,096 | 19.3 % | 2,138 | 18.9 % | +2.00% |
Respiratory Health
15.4
%
| 1,579 | 14.5 % | 1,736 | 15.4 % | +9.94% |
Vitamins, Minerals and Supplements
14.5
%
| 1,675 | 15.4 % | 1,640 | 14.5 % | -2.09% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
EMEA and Latin America
40.2
%
| 4,270 | 39.3 % | 4,545 | 40.2 % | +6.44% |
North America
37.1
%
| 4,116 | 37.9 % | 4,195 | 37.1 % | +1.92% |
APAC
22.7
%
| 2,472 | 22.8 % | 2,562 | 22.7 % | +3.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian McNamara
CEO | Chief Executive Officer | 57 | 21-07-21 |
Tobias Hestler
DFI | Director of Finance/CFO | 52 | 21-11-30 |
Franck Riot
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-15 |
Sonya Ghobrial
IRC | Investor Relations Contact | - | - |
Tamara Rogers
SAM | Sales & Marketing | - | 21-12-15 |
Lisa Paley
PRN | Corporate Officer/Principal | - | - |
Keith Choy
PRN | Corporate Officer/Principal | - | - |
Filippo Lanzi
PRN | Corporate Officer/Principal | - | - |
Mairéad Nayager
HRO | Human Resources Officer | - | 22-02-28 |
Bjarne Tellmann
LAW | General Counsel | 57 | 21-12-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Supran
BRD | Director/Board Member | - | 22-07-17 |
Dame Cox
BRD | Director/Board Member | 63 | 22-07-17 |
Tracy Clarke
BRD | Director/Board Member | 57 | 22-07-17 |
Vindi Banga
BRD | Director/Board Member | 69 | 22-07-17 |
Deirdre Mahlan
BRD | Director/Board Member | 61 | 22-07-17 |
David Lewis
CHM | Chairman | 59 | 22-05-22 |
David Denton
BRD | Director/Board Member | 59 | 23-02-28 |
Tobias Hestler
DFI | Director of Finance/CFO | 52 | 21-11-30 |
Brian McNamara
CEO | Chief Executive Officer | 57 | 21-07-21 |
Asmita Dubey
BRD | Director/Board Member | - | 22-07-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,132,301,104 | 7,072,820,336 ( 77.45 %) | 0 | 77.45 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
GlaxoSmithKline Consumer Pvt Ltd.
GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The private company is based in Patiala, India and was founded in 2014. |
Pharmaceuticals: Major
|
GlaxoSmithKline Consumer Healthcare Finance Ltd.
GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the private company is based in Brentford, UK. |
Financial Conglomerates
|
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. |
Financial Conglomerates
|
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd.
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The private company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014. |
Financial Conglomerates
|
Haleon UK Trading Services Ltd.
Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The private company is based in Weybridge, UK. Founded in 2012. |
Drugstore Chains
|
GSK Consumer Healthcare Capital US LLC
GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a private company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE. |
Medical/Nursing Services
|
Haleon UK Capital Plc
Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara. |
Regional Banks
|
Gsk Consumer Healthcare Capital Nl BV
Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The private company is located in the UK. |
Pharmaceuticals: Other
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.96% | 38.04B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- HLN Stock
- Company Haleon plc